Sunday November 8 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Boston Medical Center


Contact Details:
One Boston Medical Center Place
Boston
MA
2118
United States of America
Tel:
Fax:
Email:amy.gleason@bmc.org

Loading...

Recent Publications by Boston Medical Center:

New mTOR inhibitor for renal cell cancer.
This article presents an in-depth, qualitative assessment of the needs,...
29th October, 2009
Boston Medical Center, Boston, Massachusetts, USA. Oncology (Williston Park). 2009 Jul;23(8 Suppl):54-6.
Bevacizumab for renal cell carcinoma, glioblastoma, and other solid tumors.
This article presents an in-depth, qualitative assessment of the needs,...
28th October, 2009
Boston Medical Center, Boston, Massachusetts, USA. Oncology (Williston Park). 2009 Oct;23(11 Suppl):54-6.
Drug essentials. An alkylating agent for CLL and NHL.
This article presents an in-depth, qualitative assessment of the needs,...
28th October, 2009
Boston Medical Center, Boston, Massachusetts, USA. Oncology (Williston Park). 2009 Apr;23(4 Suppl):55-6.
Drug essentials. Small molecule multitargeted TKI therapy.
This article presents an in-depth, qualitative assessment of the needs,...
28th October, 2009
Boston Medical Center, Boston, Massachusetts, USA. Oncology (Williston Park). 2008 Oct;22(11 Suppl):47-8.
Research during pediatric residency training: outcome of a senior resident block rotation.
BACKGROUND: The Pediatric Residency Review Committee requires programs to...
24th October, 2009
Boston Medical Center, Department of Pediatrics, Boston University School Pediatrics. 2009 Oct;124(4):1126-34. Epub 2009 Sep 28.
DOI Direct Link

View more Boston Medical Center research publications.

Press Releases on Boston Medical Center:

BioPortfolio Logo
Carefx Named an Innovative Information Access 'Company to Watch' By Leading Market Research Firm 28th October, 2009 Carefx Corporation
SCOTTSDALE, Ariz., Oct. 28 /PRNewswire/ -- Carefx Corporation, a leading provider of interoperable workflow solutions to advance the quality and safety of patient care, is listed among the "
Boston Medical Center Managing H1N1 Flu Vaccination for its Community with Carefx's New Immunization Management Solution 27th October, 2009 Carefx Corporation
SCOTTSDALE, Ariz., Oct. 27 /PRNewswire/ -- Acknowledging the critical role of Centers for Disease Control and Prevention (CDC) guidelines in ensuring the safety and efficacy of H1N1 vaccinations,
Limited English Speaking Patients Closer to Being Guaranteed Quality, Equitable Healthcare 12th October, 2009 Language Line Services
-- Rita Weil, Ph.D., medical interpreter and educator, PA The board will review other applications received and may appoint other members and will work to ensure all stakeholders are involved
Orexigen(R) Therapeutics Phase 2b Trial for Empatic(TM) Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus Comparators in Obese Patients 30th September, 2009 Orexigen Therapeutics, Inc.
-- Adverse events and laboratory findings appeared to be consistent with the individual components of Empatic. There were no serious adverse events attributed by investigators to
Carefx's New Referral Management Solution Increases Hospital Referral Volume, Enhances Collaboration Among Specialists, PCPs and Patients 11th August, 2009 Carefx Corporation
-- Comprehensive Reporting "Carefx's eReferral addresses the business goals and challenges of healthcare executives," said Qi Li, M.D., Vice President of Clinical Strategies for

BioNews Results for Boston Medical Center:

Post-transplant Prophylactic Antiviral Treatment Does Not Prevent Recurrent Hepatitis C: Presented at AASLD
Doctors Guide:  Nov 1 2009 9:08PM Matching: boston medical center
Local Excision Alone Without Irradiation for Ductal Carcinoma In Situ of the Breast: A Trial of the Eastern Co
Journal of Clinical Oncology:  Oct 31 2009 5:48PM Matching: boston medical center
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular
Journal of Clinical Oncology:  Oct 31 2009 5:47PM Matching: boston medical center
Randomized Phase II Study of Gemcitabine Administered at a Fixed Dose Rate or in Combination With Cisplatin, D
Journal of Clinical Oncology:  Oct 31 2009 5:51PM Matching: boston medical center
Boston Medical Center's Elders Living At Home Program Receives Grant From Admninistration On Aging
Medical News Today:  Oct 31 2009 7:49AM Matching: boston medical center
Promote your company here: BioNewsCast - Press Release Distribution

View more Boston Medical Center news.

Boston Medical Center Clinical Trials:

A Multicenter Randomized Trial Comparing Antiglide and Lateral Plate Fixation in Ankle Fractures

Boston Medical Center Patents:

US Patent No.Title
7517667 Methods for promoting, inhibiting and detecting toxin entry into cells
5763250 Chimeric toxins
5863891 Chimeric toxins
5932471 DNA encoding chimeric toxin
6309817 Identification of virulence determinants activators in prokaryotic pathogens

View more Boston Medical Center patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 320 individuals from Boston Medical Center using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 255 times since April 2007, the link to the organisation's website has been followed 0 times

Search for more companies in Boston

Search for more companies in MA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Boston Medical Center

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.